E. Hillyer

发表

Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size

D. Postma, D. Price, E. Israel, 2017, Pulmonary Therapy.

Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.

D. Price, P. Dorinsky, E. Israel, 2013, The Journal of allergy and clinical immunology.

AB027. Long-acting beta-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

C. Murray, K. Richardson, A. Burden, 2016 .

Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.

D. Price, J. Haughney, R. Lewis, 2013, Respiratory medicine.

Complementing the randomized controlled trial evidence base. Evolution not revolution.

A. Buist, E. Bateman, N. Papadopoulos, 2014, Annals of the American Thoracic Society.

Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.

Dirkje S Postma, David Price, Jonathan Grigg, 2015, The journal of allergy and clinical immunology. In practice.

Effectiveness of Same Versus Mixed Asthma Inhaler Devices: A Retrospective Observational Study in Primary Care

David Price, Julie von Ziegenweidt, Alan Kaplan, 2012, Allergy, asthma & immunology research.

Achieving asthma control in practice: understanding the reasons for poor control.

D. Price, R. Horne, J. Haughney, 2008, Respiratory medicine.

Device type and real-world effectiveness of asthma combination therapy: an observational study.

D. Price, N. Roche, Amanda J Lee, 2011, Respiratory medicine.

Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma.

D. Price, Amanda J Lee, E. Sims, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

D. Postma, D. Price, P. Dorinsky, 2016, Pulmonary Therapy.

Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study

D. Price, Amanda J Lee, E. Sims, 2013, Primary care respiratory journal : journal of the General Practice Airways Group.

Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler

D. Postma, D. Price, E. Israel, 2016, ERJ Open Research.

Mobulid Rays off Eastern Venezuela (Chondrichthyes, Mobulidae)

E. Hillyer, G. Notarbartololo-Di-Sciara, 1989 .

Effect of Inhaled Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control

A. Chisholm, A. Burden, E. Hillyer, 2013 .

Asthma control with extrafine‐particle hydrofluoroalkane–beclometasone vs. large‐particle chlorofluorocarbon–beclometasone: a real‐world observational study

D. Price, P. Dorinsky, E. Israel, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Blood eosinophil count and exacerbation risk in patients with COPD

Todor A Popov, D. Postma, I. Pavord, 2017, European Respiratory Journal.

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD

D. Price, J. Haughney, Amanda J Lee, 2011, Journal of asthma and allergy.

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

D. Postma, D. Price, E. Israel, 2014, International journal of chronic obstructive pulmonary disease.

Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.

D. Postma, D. Price, P. Dorinsky, 2015, Annals of the American Thoracic Society.

Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.

D. Postma, D. Price, E. Israel, 2017, The journal of allergy and clinical immunology. In practice.

Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.

D. Postma, D. Price, E. Israel, 2015, American journal of respiratory and critical care medicine.

AN OUTBREAK OF SARCOCYSTIS IN A COLLECTION OF PSITTACINES

C. Atkinson, J. K. Frenkel, E. Greiner, 1991 .

Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy

D. Postma, D. Price, P. Dorinsky, 2013 .

Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

D. Postma, D. Price, E. Israel, 2016, BMC Pulmonary Medicine.

Inhaled Corticosteroids for Asthma Therapy in Young Children: Does Aerosol Particle Size Matter? Reply

D. Postma, D. Price, N. Roche, 2016 .

Megaesophagus in nine ferrets.

J. Fox, E. Hillyer, J. Murphy, 1994, Journal of the American Veterinary Medical Association.

Inhaled corticosteroid dose-response on blood eosinophils in asthma - Authors' reply.

I. Pavord, D. Price, Andrew M. Wilson, 2016, The Lancet. Respiratory medicine.

Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks

D. Price, N. Roche, J. Grigg, 2018, Journal of asthma and allergy.

Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.

Todor A Popov, D. Postma, D. Price, 2017, The journal of allergy and clinical immunology. In practice.

Chapter 23 – Biology, Husbandry, and Clinical Techniques of Guinea Pigs and Chinchillas

E. Hillyer, T. Donnelly, K. Quesenberry, 2004 .

Bile Duct Carcinoma in Two out of Ten Amazon Parrots with Cloacal Papillomas

S. Moroff, E. Hillyer, H. Hoefer, 1991 .

Pet Rabbits

E. Hillyer, 1994, Veterinary Clinics of North America: Small Animal Practice.

Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991).

S. Moroff, M. Peterson, E. Hillyer, 1993, Journal of the American Veterinary Medical Association.

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

Dirkje S Postma, Nicolas Roche, D. Postma, 2017, Pragmatic and observational research.

Pragmatic and Observational Research Dovepress an Evaluation of Exact Matching and Propensity Score Methods as Applied in a Comparative Effectiveness Study of Inhaled Corticosteroids in Asthma Jetty a Overbeek 4

D. Postma, D. Price, N. Roche, 2022 .

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Stifle Luxation Repair in a Moluccan Cockatoo and a Barn Owl

E. Hillyer, K. Rosenthal, David Mathiessen, 1992 .

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population

D. Price, J. Soriano, M. Kerkhof, 2017, Thorax.

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

Mike Thomas, Ian D Pavord, Jonathan D Campbell, 2015, The Lancet. Respiratory medicine.

Efficacy versus effectiveness trials: informing guidelines for asthma management

D. Price, E. Hillyer, T. van der Molen, 2013, Current opinion in allergy and clinical immunology.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Curr Allergy Asthma Rep (2011) 11:526–538 DOI 10.1007/s11882-011-0222-7 ASTHMA (WILLIAM J. CALHOUN AND JEAN BOUSQUET, SECTION EDITORS) Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness

D. Price, J. Bousquet, N. Roche, 2011 .

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

D. Price, E. Juniper, L. Shepstone, 2011, The New England journal of medicine.

Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.

D. Price, P. Dorinsky, E. Israel, 2010, The Journal of allergy and clinical immunology.

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study

D. Price, J. Haughney, Amanda J Lee, 2010, ClinicoEconomics and outcomes research : CEOR.

Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal.

D. Price, E. Israel, H. Chrystyn, 2017, Journal of aerosol medicine and pulmonary drug delivery.

Natural history of asthma: persistence versus progression-does the beginning predict the end?

L. Bacharier, R. Panettieri, E. Hillyer, 2008, The Journal of allergy and clinical immunology.

The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey.

E. Hillyer, D. Price, J. Rosenzweig, 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

The impact of migraine on work, family, and leisure among young women – a multinational study

S. Bolge, E. Hillyer, R. Leira, 2004, Current medical research and opinion.

Question cause of hypercalcemia in a rabbit.

E. Hillyer, D. Mader, H. Hoefer, 1995, Journal of the American Veterinary Medical Association.

Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma

D. Price, E. Hillyer, 2014, Expert review of respiratory medicine.

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study

D. Postma, D. Price, E. Israel, 2014, npj Primary Care Respiratory Medicine.

D. Postma, D. Price, E. Israel, 2016, Allergy, asthma & immunology research.

Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.

D. Price, C. Murray, K. Richardson, 2017, The journal of allergy and clinical immunology. In practice.

Adrenal gland tumors in ferrets.

E. Hillyer, 1994, Journal of the American Veterinary Medical Association.

Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.

Todor A Popov, D. Postma, D. Price, 2017, Journal of Allergy and Clinical Immunology: In Practice.

Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.

D. Postma, D. Price, E. Israel, 2015, Journal of Allergy and Clinical Immunology: In Practice.

Blood eosinophil count and exacerbation risk in patients with COPD

Todor A Popov, D. Postma, I. Pavord, 2017, European Respiratory Journal.

Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks

D. Price, N. Roche, J. Grigg, 2018, Journal of asthma and allergy.

Complementing the randomized controlled trial evidence base. Evolution not revolution.

A. Buist, E. Bateman, N. Papadopoulos, 2014, Annals of the American Thoracic Society.

Device type and real-world effectiveness of asthma combination therapy: an observational study.

D. Price, N. Roche, Amanda J Lee, 2011, Respiratory medicine.

Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.

L. Shepstone, J. Murdoch, J. Ayres, 2010, PharmacoEconomics.

Achieving asthma control in practice: understanding the reasons for poor control.

D. Price, R. Horne, J. Haughney, 2008, Respiratory medicine.

Reply.

D. Postma, N. Roche, G. Colice, 2016, The journal of allergy and clinical immunology. In practice.